Crewe Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4
| Closed | -$290 | – | 772 |
|
|
2025
Q1 | $290 | Buy |
+4
| New | +$290 | ﹤0.01% | 675 |
|
|
2024
Q4 | – | Sell |
-290
| Closed | -$19.1K | – | 701 |
|
|
2024
Q3 | $19.1K | Hold |
290
| – | – | ﹤0.01% | 412 |
|
|
2024
Q2 | $26.8K | Hold |
290
| – | – | ﹤0.01% | 496 |
|
|
2024
Q1 | $27.7K | Buy |
+290
| New | +$27.7K | ﹤0.01% | 447 |
|
|
2023
Q2 | – | Sell |
-108
| Closed | -$8.94K | – | 922 |
|
|
2023
Q1 | $8.94K | Sell |
108
-121
| -53% | -$10K | ﹤0.01% | 570 |
|
|
2022
Q4 | $17.1K | Sell |
229
-144
| -39% | -$10.7K | ﹤0.01% | 450 |
|
|
2022
Q3 | $31K | Buy |
373
+76
| +26% | +$6.32K | 0.01% | 385 |
|
|
2022
Q2 | $28K | Buy |
+297
| New | +$28K | 0.01% | 363 |
|
|
2021
Q4 | – | Sell |
-30
| Closed | -$3K | – | 422 |
|
|
2021
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 330 |
|
|
2021
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 369 |
|
|
2021
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 393 |
|
|
2020
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 382 |
|
|
2020
Q3 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 499 |
|